Great Point Partners LLC Cytokinetics Inc Transaction History

Great Point Partners LLC

$216 Million
Q3 2024

A detailed history of Great Point Partners LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Great Point Partners LLC holds 316,000 shares of CYTK stock, worth $15.4 Million. This represents 7.71% of its overall portfolio holdings.

Number of Shares

316,000

Previous 474,202 33.36%

Holding current value

$15.4 Million

Previous $25.7 Million 35.06%

% of portfolio

7.71%

Previous 6.81%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$51.22 - $60.16 $8.1 Million - $9.52 Million	-158,202 Reduced 33.36%	316,000 $16.7 Million
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $13 Million - $20.4 Million	272,000 Added 134.52%	474,202 $25.7 Million
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $19 Million - $32.2 Million	-297,798 Reduced 59.56%	202,202 $14.2 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $2.69 Million - $8.35 Million	-100,000 Reduced 16.67%	500,000 $41.7 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $3.26 Million - $4.08 Million	100,000 Added 20.0%	600,000 $19.6 Million
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $16.7 Million - $22.9 Million	500,000 New	500,000 $17.6 Million
Q2 2022 Aug 15, 2022	SELL	$33.93 - $48.92 $1.36 Million - $1.96 Million	-40,000 Reduced 6.15%	610,000 $24 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $8.92 Million - $13.8 Million	300,000 Added 85.71%	650,000 $23.9 Million
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $1.42 Million - $1.92 Million	-41,429 Reduced 10.58%	350,000 $16 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $7.26 Million - $14 Million	391,429 New	391,429 $14 Million
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $38.9 Million - $72.9 Million	-2,549,525 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $21.2 Million - $29.8 Million	1,028,890 Added 67.66%	2,549,525 $55.2 Million
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $9.55 Million - $21.1 Million	856,538 Added 128.98%	1,520,635 $35.8 Million
Q1 2020 May 15, 2020	BUY	$8.75 - $16.3 $4.41 Million - $8.22 Million	504,024 Added 314.87%	664,097 $7.83 Million
Q4 2019 Feb 14, 2020	BUY	$7.95 - $11.84 $1.27 Million - $1.9 Million	160,073 New	160,073 $1.7 Million
Q1 2019 May 14, 2019	SELL	$5.95 - $10.19 $18.9 Million - $32.3 Million	-3,173,288 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$5.91 - $9.29 $5.87 Million - $9.23 Million	993,600 Added 45.58%	3,173,288 $20.1 Million
Q3 2018 Nov 14, 2018	BUY	$6.4 - $9.85 $4.71 Million - $7.24 Million	735,207 Added 50.9%	2,179,688 $21.5 Million
Q2 2018 Aug 14, 2018	BUY	$6.9 - $9.9 $9.97 Million - $14.3 Million	1,444,481 New	1,444,481 $12 Million

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.6B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Account

Great Point Partners LLC Cytokinetics Inc Transaction History